Company Quick10K Filing
Maximus
10-Q 2021-03-31 Filed 2021-05-06
10-Q 2020-12-31 Filed 2021-02-04
10-K 2020-09-30 Filed 2020-11-19
10-Q 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-07
10-Q 2019-12-31 Filed 2020-02-06
10-K 2019-09-30 Filed 2019-11-26
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-09
10-Q 2018-12-31 Filed 2019-02-07
10-K 2018-09-30 Filed 2018-11-20
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-10
10-Q 2017-12-31 Filed 2018-02-08
10-K 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-03
10-Q 2017-03-31 Filed 2017-05-04
10-Q 2016-12-31 Filed 2017-02-09
10-K 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-08-04
10-Q 2016-03-31 Filed 2016-05-06
10-Q 2015-12-31 Filed 2016-02-05
10-K 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-07
10-Q 2015-03-31 Filed 2015-05-08
10-Q 2014-12-31 Filed 2015-02-06
10-K 2014-09-30 Filed 2014-11-17
10-Q 2014-06-30 Filed 2014-08-08
10-Q 2014-03-31 Filed 2014-05-09
10-Q 2013-12-31 Filed 2014-02-07
10-K 2013-09-30 Filed 2013-11-19
10-Q 2013-06-30 Filed 2013-08-09
10-Q 2013-03-31 Filed 2013-05-10
10-Q 2012-12-31 Filed 2013-02-08
10-K 2012-09-30 Filed 2012-11-16
10-Q 2012-06-30 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-04
10-Q 2011-12-31 Filed 2012-02-03
10-K 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-09
10-Q 2011-03-31 Filed 2011-05-10
10-Q 2010-12-31 Filed 2011-02-08
10-K 2010-09-30 Filed 2010-11-19
10-Q 2010-06-30 Filed 2010-08-05
10-Q 2010-03-31 Filed 2010-05-06
10-Q 2009-12-31 Filed 2010-02-04
8-K 2020-11-23
8-K 2020-08-11
8-K 2020-06-19
8-K 2020-05-12
8-K 2020-04-03
8-K 2020-03-23
8-K 2020-02-10
8-K 2019-11-22
8-K 2019-08-12
8-K 2019-08-02
8-K 2019-05-13
8-K 2019-03-29
8-K 2019-03-22
8-K 2019-02-11
8-K 2019-01-16
8-K 2019-01-10
8-K 2018-12-14
8-K 2018-11-26
8-K 2018-10-09
8-K 2018-08-13
8-K 2018-05-14
8-K 2018-03-15
8-K 2018-02-12
8-K 2018-01-16

Maximus Financials

MMS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
Supernova Partners Acquisition Co III, Ltd. (STRE-WT)
1347 Capital Corp (TFSC)
Ameri Metro, Inc. (formerly Yellowwood) (ARMT)
Gores Technology Partners, Inc. (GTPAW)
Bioquest Corp (BQST)
BriaCell Therapeutics Corp. (BCTXW)
Ameren Illinois Co (AILNP)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash1771832041731912301691891671871881261211311831581491158275516151667095104166197253229349625479116
Accounts Receivable115138126147150141158173199205221273278310275263265340378396425433421444426432377394439415399358487492526477
Inventory
PP&E11912111511812112413514258596318173717221583103118299138137136328122113107274969185273817785330
Assets5375735905655846166526957067447598588448979229018929551,2761,2801,2761,3431,2981,3491,2961,3161,2831,3511,4021,4301,4011,4621,6691,6881,6911,746
Accounts Payable54626255626761
Long-Term Debt12222222222111116721124528621116615111616112120750
Liabilities180190194191192205222244244251268328305325334345334367635664663679593596534493393405394364345376552520476498
Stockholders' Equity3573833963743924114304514624934915305395725895565585876386126096597027497598208869401,0011,0631,0521,0841,1151,1651,2141,248
Income Statement ($MM)2010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue214227238250240245266301286326334384407439420435467529572579557606617623608622600621623613598558665737731755
Cost of Revenue158164172182180179188216210229240267301379307322348398429453447459466470463470448458471464443420505567556587
Gross Profit5663666860657985779795117106121113113119131144125110148151153145152152163152149155139159169174168
R&D
SG&A293435353338444342474960535957625459676064667068656968827073707480788282
Tax10111210202421172426282519293129272727222024241720302123
Net Income171820261814202421332836344134364247423627495351475358556055604656626360
Cash Flow ($MM)2010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating3063427284116301029503242358948575119251208672716611585387972134596813693
Cash Investing-5-6-6-10-1-5-72-8-10-8-17-95-8-11-11-20-14-33-315-31-13-48-14-12-7-5-5-8-6-7-28-5-412-8-21-43
Cash Financing-54-9-41-11-0-2-4-21-1-18-2-37-13-29-48-48-51621-1138-81-43-57-38-103-18-1-17-66-859-68-91-11